US Edition
RWJBarnabas Health and Rutgers Cancer Institute to Present Practice-Changing Research at 2025 ASCO Annual Meeting
- Researchers and clinicians affiliated with RWJBarnabas Health along with the Rutgers Cancer Institute are set to unveil new findings in cancer research at the 2025 ASCO Annual Meeting, scheduled to take place in Chicago from May 30 to June 3.
- This presentation is based on comprehensive research across various cancer types, including a study involving more than thirteen thousand patients with cancer of unknown primary, where liquid biopsy detected targetable genetic alterations in nearly one-third of cases.
- Additional key findings include significant improvements in depression among young adults, 64% pathologic complete response in certain breast cancers, and socioeconomic barriers reducing clinical trial participation.
- For instance, 29% of cancer of unknown primary patients had actionable mutations detected by liquid biopsy, and patients in overlapping food and clinical trial deserts had a 27% lower enrollment rate.
- These results emphasize RWJBarnabas and Rutgers' commitment to advancing patient-centric care and novel therapies as they expand treatment access through recent institutional developments like the Morris Cancer Center.
55 Articles
55 Articles
The Conway Daily Sun
RWJBarnabas Health and Rutgers Cancer Institute to Present Practice-Changing Research at 2025 ASCO Annual Meeting
Expert-led studies will highlight advances across multiple cancer types and examine real-world insights shaping the future of personalized oncology care
Moffitt to Present Plenary and Late-Breaking Data on Blood, Melanoma and Brain Metastases at ASCO 2025
Moffitt Cancer Center will play a key role at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 30 to June 3 in Chicago. Physician-scientists and researchers from Moffitt are contributing to more than 30 oral, rapid-oral and poster presentations, offering new data and perspectives that could help shape the future of cancer care.
Moffitt to Unveil Plenary and Late-Breaking Findings on Blood, Melanoma,
TAMPA, Fla. – The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, set to convene from May 30 to June 3 in Chicago, stands as a pivotal forum for groundbreaking cancer research, showcasing innovations destined to reshape the oncology landscape. This year, the Moffitt Cancer Center emerges as a significant contributor, with its physician-scientists and investigators presenting new data and cutting-edge insights through more than …
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
